Skip to content

Study on the role and correlation of pre-transplantation non-HLA antibody in renal transplantation ABMR

Study on the role and correlation of pre-transplantation non-HLA antibody in renal transplantation ABMR

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200061369
Enrollment
Unknown
Registered
2022-06-22
Start date
2022-08-01
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal transplantation ABMR

Interventions

case gruop:Not Applicable

Sponsors

Shanxi Benthune Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to No maximum

Inclusion criteria

Inclusion criteria: 1) The organ transplantation Center of our hospital has obtained kidneys from the National organ allocation system to determine the patients for kidney transplantation; 2) The patient is older than 12 years; 3) The patient was the first transplant recipient; 4) No active hepatitis, tuberculosis and other infections; 5) Voluntarily sign written informed consent.

Exclusion criteria

Exclusion criteria: 1) Preoperative test of complement dependent cytotoxicity (CDC) =10%; 2) The ABO blood groups of the donor recipients were not compatible before surgery; 3) Renal malperfusion occurred in the donor kidney received by the patient; 4) Pathologically confirmed cell rejection occurred before ABMR; 5) The patient presented hLA-DSA positive after kidney transplantation; 6) Patients who have not completed kidney transplantation for some reason; 7) Primary nonfunction; 8) The patient died within 1 month after surgery, or the transplanted kidney was removed due to surgical or infectious complications; 9) Patients receiving combined organ transplantation were excluded from the group.

Design outcomes

Primary

MeasureTime frame
non-HLA antibodies;HLA antibodies;

Secondary

MeasureTime frame
Microcytotoxicity;blood routine examination;routine urine test;Immunosuppressive blood drug concentration;

Countries

China

Contacts

Public ContactZhenxing Wang

Shanxi Bethune Hospital Organ Transplant Center

yzzxwangzhenxing@163.com+86 13503547391

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026